76 related articles for article (PubMed ID: 3606153)
1. [Antitumor effects of the tumor necrosis factor (PAC-4D) against human gynecological carcinoma transplanted into nude mice].
Suzumori K; Yasui Y; Yagami Y; Kimura K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2341-6. PubMed ID: 3606153
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
Suzumori K; Yasui Y; Suzumori K; Yagami Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
[TBL] [Abstract][Full Text] [Related]
3. Potential limitation of growth-inhibitory action of recombinant human tumor necrosis factor (PAC-4D) due to easy induction of resistance: evidence in vitro.
Hanada M; Shimoyama M
Jpn J Cancer Res; 1987 Nov; 78(11):1266-73. PubMed ID: 2826376
[TBL] [Abstract][Full Text] [Related]
4. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
Creasey AA; Reynolds MT; Laird W
Cancer Res; 1986 Nov; 46(11):5687-90. PubMed ID: 3756916
[TBL] [Abstract][Full Text] [Related]
5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
6. [Direct anti-tumor effect of recombinant human IFN-gamma evaluated in ovarian pseudomyxoma peritoneally transplanted into nude mice].
Miyahara K; Nishimura H; Hamaguchi K; Ookura N; Hamai J; Ushijima H; Yakushiji M; Kato T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):411-5. PubMed ID: 3101605
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
8. [Study on human lymphoblastoid interferon-alpha (MOR-22): Part III. Antitumor effect on nude mouse-transplanted human tumors].
Nobuhara M; Kanamori T; Harada Y; Horisawa Y; Ishii K; Yanagihara Y; Kiyonaga J
Gan To Kagaku Ryoho; 1986 Jan; 13(1):134-8. PubMed ID: 3753641
[TBL] [Abstract][Full Text] [Related]
9. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.
Kobayashi H; Yagyu T; Inagaki K; Kondo T; Suzuki M; Kanayama N; Terao T
Cancer; 2004 Feb; 100(4):869-77. PubMed ID: 14770446
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].
Zhou L; Yan MX; Yao M; Feng YJ
Ai Zheng; 2005 Nov; 24(11):1312-6. PubMed ID: 16552954
[TBL] [Abstract][Full Text] [Related]
12. [An in vitro and in vivo study of antitumor effects of rHTNF-alpha on human ovarian cancer].
Zhao EF; Zhou MQ; Fu CY
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):273-6. PubMed ID: 7805556
[TBL] [Abstract][Full Text] [Related]
13. Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.
Lenk H; Tanneberger S; Müller U; Shiga T
Arch Geschwulstforsch; 1988; 58(2):89-97. PubMed ID: 3377652
[TBL] [Abstract][Full Text] [Related]
14. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. [Basic study on interferon-beta: Part IV. Antitumor effect on nude mouse-transplanted human tumors].
Nobuhara M; Kanamori T; Ashida Y; Horisawa Y; Harada Y; Asami T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2117-22. PubMed ID: 3717959
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
20. [The antimetastatic effects of BJA-II on nude mice with highly metastatic human ovarian carcinoma].
Gao YL; Xu SH; Mu HZ
Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):404-7, 444-5. PubMed ID: 8001416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
